Abstract
Introduction

Leukocytosis and hypercalcemia are often found in patients with cancer. Recent studies have demonstrated that either granulocyte-colony stimulating factor (G-CSF) or parathyroid hormone-related peptide (PTH-rP) could be produced by cancer cells (1-6). Furthermore, cancer cells may produce not only G-CSF but also multiple other cytokines such as interleukin (IL)-1, IL-6, IL-8 and M-CSF (7-9). Here, we report an autopsied case of primary pulmonary squamous cell carcinoma (SCC) associated with leukocytosis, hypercalcemia, hemophagocytosis, reactive lymphadenopathy and diffuse glomerular mesangial proliferation via the production of PTH-rP, G-CSF and IL-6.
Case Report
, suggesting the (Fig. 4) . (Fig. 5) (Fig. 6B) . (1, (11) (12) (13) (14) . All of these patients were Japanese, and such lung cancers might be more prevalent in the Asian ethnic background. F i g u r e 7 . P r o p o s e d s e q u e n c e o f e v e n t s i n t h e p r e s e n t c a s e . essential in the G-CSF promoter for the response to specific cytokines and mitogens (17, 18 
F i g u r e 5 . A p o s i t i v e c y t o p l a s mi c i mmu n o s t a i n i n g f o r t umo r c e l l s wi t h a n t i -G-CS F a n t i b o d y ( × 4 0 0 ) .
F i g u r e 6 . ( A) A p o s i t i v e c y t o p l a s mi c i mmu n o s t a i n i n g f o r t umo r c e l l s wi t h a n t i -P T H-r P a n t i b o d y ( × 4 0 0 ) . ( B ) A n e g a t i v e c y t o p l a s mi c i mmu n o s t a i n i n g f o r t u mo r c e l l s wi t h n o r ma l mo u s e I g G1 ( × 4 0 0 ) .
The lung tumor obtained from autopsy was subject to immunohistochemistry using antibodies against G-CSF
Discussion
G-CSF is one of the hematopoietic growth factors that causes leukocytosis. More than 30 cases of G-CSFproducing lung cancer have been reported ever since the identification of the first case with leukocytosis due to G-CSF production by lung cancer in 1977 (2). Most of them were histologically SCC and large cell carcinoma. On the other hand, PTH-rP was purified from a human lung cancerderived cell line as a causative factor for humoral hypercalcemia of malignancy (HHM), and its primary structure was determined in 1987 (3). HHM is frequently associated with a squamous cell type of lung cancer, and PTH-rP gene expression was demonstrated in it (4). Iguchi et al (5) first reported that high concentrations of PTH-rP were present in the serum of a patient with SCC. The present case showed severe granulocytosis and hypercalcemia as well as elevated serum PTH-rP and G-CSF levels. Furthermore, positive cytoplasmic reactions to antibodies against G-CSF and PTH-rP were shown in SCC at the autopsy. Thus, the patient was diagnosed as primary pulmonary SCC associated with granulocytosis and hypercalcemia possibly via the production of both PTH-rP and G-CSF. It has been reported that patients with lung cancer occasionally have accompanying marked leukocytosis and hypercalcemia (6). However, our literature search revealed that there have only been a few case reports of lung cancer producing both PTH-rP and G-CSF and causing leukocytosis and hypercalcemia to date
IL-6 is known to differentiate B-cell with the generation of antibodies and to breed and differentiate nerve cells (15). It has been reported that PTH-rP stimulates IL-6 secretion from osteoblasts in bone marrow after binding to its receptor on the cells (16), and that an IL-6 consensus sequence is
